|
1
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.PubMed/NCBI
|
|
2
|
Ferlay J, Shine HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu X, Liang H, Deng J, et al: Different
parts of the patients with gastric cancer radical surgery clinical
pathological characteristics and prognosis. J Chin Gastrointest
Surg. 13:181–184. 2010.
|
|
4
|
Keeney S and Bauer TL: Epidemiology of
adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N
Am. 15:687–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crane SJ, Richard Locke G III, Harmsen WS,
Diehl NN, Zinsmeister AR, Joseph Melton L III, Romero Y and Talley
NJ: The changing incidence Of oesophageal and gastric
adenocarcinoma by anatomic sub-site. Aliment Phamacol Ther.
25:447–453. 2007. View Article : Google Scholar
|
|
6
|
Xu B and Wang J: Gastric cancer
epidemiological studies. Chin J Cancer Prev Treat. 1:1–7. 2006.
|
|
7
|
Zou X, Sun X, Chen W, et al: gastric
cancer and death of Chinese from 2003 to 2007. Tumor. 32:109–114.
2012.
|
|
8
|
Xu GW and Si JH: The stomach and duodenum
diseases. Surgery (Beijing). People's Health Publishing House.
1440–1467. 2008.(In Chinese).
|
|
9
|
Sun XD, Mu R, Zhou YS, Dai XD, Zhang SW,
Huangfu XM, Sun J, Li LD, Lu FZ and Qiao YL: Analysis of mortality
rate of stomach cancer and its trend in twenty years in China.
Zhonghua Zhong Liu Za Zhi. 26:4–9. 2004.(In Chinese). PubMed/NCBI
|
|
10
|
Bornschein J, Rokkas T, Selgrad M and
Malfertheiner P: Gastric cancer: Clinical aspects, epidemiology and
molecular background. Helicobacter. 16(Suppl 1): S45–S52. 2011.
View Article : Google Scholar
|
|
11
|
Correia M, Machado JC and Ristimäki A:
Basic aspects of gastric cancer. Helicobacter. 14(Suppl 1):
S36–S40. 2009. View Article : Google Scholar
|
|
12
|
Li FP and Montesano R: Interactions of
cancer susceptibility genes and environmental carcinogens. American
Association for Cancer Research (AACR)-International Agency for
Reserch on Cancer (IARC) Joint Conference. Cancer Res.
54:4243–4247. 1994.PubMed/NCBI
|
|
13
|
Jakszyn P and Gonzalez CA: Nitrosamine and
related food intake and gastric and oesophageal cancer risk: A
systematic review of the epidemiological evidence. World J
Gastroenterol. 12:4296–4303. 2006.PubMed/NCBI
|
|
14
|
Kreuzer M, Straif K, Marsh JW, et al:
Occupational dust and radiation exposure and mortality from stomach
cancer among German uranium miners, 1946–2003. Occup Environ Med.
69:217–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakamura K, Ueyama T, Yao T, et al:
Pathology and prognosis of gastric carcinoma. Findings in 10,000
patients who underwent primary gastrectomy. Cancer. 70:1030–1037.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adachi Y, Yasuda K, Inomata M, et al:
Pathology and prognosis of gastric carcinoma: Well versus poorly
differentiated type. Cancer. 89:1418–1424. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He Y, Wang J, Zhao Z, Zheng K and Cui Y:
EUS and comparative study of spiral CT TNM staging of gastric
surgery. Zhong Guo Xiao Hua Nei Jing. 2:21–24. 2008.(In
Chinese).
|
|
19
|
Yang Q, Zhu Z and Yutaka Y: Clinical and
pathological features of early gastric cancer with distant
metastasis. Zhong Guo Shi Yong Wai Ke Za Zhi. 11:873–875. 2007.(In
Chinese).
|
|
20
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Creighton CJ, Li X, Landis M, Dixon JM,
Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A,
Herschkowitz JI, et al: Residual breast cancers after conventional
therapy display mesenchymal as well as tumor-initiating features.
Proc Natl Acad Sci USA. 106:13820–13825. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Shi M, Yu GZ, et al:
Interleukin-8, a promising predictor for prognosis of pancreatic
cancer. World J Gastroenterol. 18:1123–1129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Curley MD, Therrien VA, Cummings CL,
Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden
DT, Rueda BR and Foster R: CD133 expression defines a tumor
initiating cell population in primary human ovarian cancer. Stem
Cells. 27:2875–2883. 2009.PubMed/NCBI
|
|
28
|
Taghizadeh R, Noh M, Huh YH, et al: CXCR6,
a newly defined biomarker of tissue-specific stem cell asymmetric
self-renewal, identifies more aggressive human melanoma cancer stem
cells. PLoS One. 5:e151832010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Constantinescu S: Stemness, Fusion and
renewal of hematopoietic and embryonic stem cells. J Cell Mol Med.
7:103–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang SH, Tsai MS, Chiang MF and Li H: A
novel NK-type, homebox gene, ENK (early embryo specific NK),
Preferentially expressed in embryonic stem cells. Gene ExPr
Patterns. 3:99–103. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripoteney sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brehm A, Ohbo K and Schöler H: The
carboxy-terminal transactivation domain of Oct-4 acquires cell
specificity through the POU domain. Mol Cell Biol. 17:165–162.
1997. View Article : Google Scholar
|
|
34
|
Hart AH, Hartley L, Ibrahim M and Robb L:
Identification, cloning and expression analysis of the pluripotency
promoting nanog genes in mouse and human. Dev Dyn. 230:187–198.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
et al: Core transcriptional regulatory circuitry in human embryonic
stem cells. Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jung M, Peterson H, Chavez L, Kahlem P,
Lehrach H, Vilo J and Adjaye J: A data integration approach to
mapping OCT4 gene regulatory networks operative in embryonic stem
cells and embryonal carcinoma cells. PLoS One. 5:e107092010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hoei-Hansen CE, Sehested A, Juhler M, Lau
YF, Skakkebaek NE, Laursen H and Rajpert-de Meyts E: New evidence
for the origin of intracranial germ cell tumours from primordial
germ cells: Expression of pluripotency and cell differentiation
markers. J Pathol. 209:25–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ye F, Zhou C, Cheng Q, Shen J and Chen H:
Stem-cell-abundant proteins nanog, nucleostemin and musashi1 are
highly expressed in malignant, cervical epithelial cells. BMC
Cancer. 8:1082008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY
and Cheung AN: Overexpression of NANOG in gestational trophoblastic
diseases: Effect on, apoptosis, cell invasion and clinical outcome.
Am J Pathol. 173:1165–1172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen Z, Xu W, Qian H, et al: Stem cell
markers Nanog detected in gastric diagnosis. Clin Exam J. 27:6–8.
2009.(In Chinese).
|
|
42
|
Reiter RE, Gu Z, Watabe T, Thomas G,
Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, et
al: Prostate stem cell antigen: A cell surface marker overexpressed
in prostate cancer. Proc Natl Acad Sci USA. 95:1735–1740. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Feng HC, Tsao SW, Ngan HY, Xue WC, Kwan
HS, Siu MK, Liao XY, Wong E and Cheung AN: Overexpression of
prostate stem cell antigen is associated with gestational
trophoblastic neoplasia. Histopathology. 52:167–174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ono H, Hiraoka N, Lee YS, Woo SM, Lee WJ,
Choi IJ, Saito A, Yanagihara K, Kanai Y, Ohnami S, et al: Prostate
stem cell antigen, a presumable organ-dependent tumor suppressor
gene, is down-regulated in gallbladder carcinogenesis. Genes
Chromosomes Cancer. 51:30–41. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saeki N, Gu J, Yoshida T and Wu X:
Prostate stem cell antigen: A Jekyll and Hyde molecule. Clin Cancer
Res. 16:3533–3538. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Study Group of Millennium Genome Project
for Cancer. Sakamoto H, Yoshimura K, Saeki N, et al: Genetic
variation in PSCA is associated with susceptibility to diffuse-type
gastric cancer. Nat Genet. 40:730–740. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lu Y, Chen J, Ding Y, Jin G, Wu J, Huang
H, Deng B, Hua Z, Zhou Y, Shu Y, et al: Genetic variation of PSCA
gene is associated with the risk of both diffuse-and
intestinal-type gastric cancer in a Chinese population. Int J
Cancer. 127:2183–2189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Qiao L and Feng Y: Genetic variations of
prostate stem cell antigen (PSCA) contribute to the risk of gastric
cancer for Eastern Asians: A meta-analysis based on 16792
individuals. Gene. 493:83–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lochhead P, Frank B, Hold GL, et al:
Genetic variation in the prostate stem cell antigen gene and upper
gastrointestinal cancer in white individuals. Gastroenterology.
140:435–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kuroda T, Tada M, Kubota H, Kimura H,
Hatano SY, Suemori H, Nakatsuji N and Tada T: Octamer and Sox
elements are required. For transcriptional cis regulation of nanog
gene expression. Mol Cell Biol. 25:2475–2485. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Brandner S: Nanog, Gli, and p53: A new
network of stemness in development and cancer. EMBO J.
29:2475–2476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zbinden M, Duquet A, Lorente-Trigos A,
Ngwabyt SN, Borges I and Altaba Ruiz IA: NANOG regulates glioma
stem cells and is Essential in vivo acting in a
cross-functional network with GLI1 and p53. EMBO J. 29:2659–2674.
2010. View Article : Google Scholar : PubMed/NCBI
|
